Dr. Hong Zhao, MD

Dr. Zhao practices at Salinas Valley Health Clinics in Salinas, California.

Dr. Zhao's NPI, 1568696896, was assigned on May 14, 2009. Dr. Zhao graduated from Southeast University Medical College in 1997. Dr. Zhao holds California license A117995.

Dr. Zhao's primary practice is Salinas Valley Health Clinics, at 505 E Romie Ln Suite A Suite A, Salinas, CA 93901-4031. The practice phone is (831) 755-1701.

Dr. Zhao's primary practice is Salinas Valley Health Clinics in Salinas, California. Dr. Zhao is also affiliated with Salinas Valley Health Medical Center. The medical group on file is Salinas Valley Health Clinics. Dmand AI also links Dr. Zhao to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhao practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zhao's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zhao is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Zhao's licenses on file in 2 states: California and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), lung cancer and lymphedema among the conditions Dr. Zhao treats.

CMS data shows 1,613 Medicare services from Dr. Zhao across 9 procedure codes in 2024, for 483 Medicare patients. Medicare paid $161,099 for them.

CMS counts 483 Medicare patients who saw Dr. Zhao in 2024. The largest group is 65 to 74, with 228 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhao's median patient age at 64, with 69% women.

In 2024, Dr. Zhao wrote 1,089 Medicare Part D claims for 194 patients. 80% of them were for generic drugs. CMS names the drug for 894 of them, across 26 drugs with 11 or more claims each, at $673,327 in total drug cost. In 2023, CMS named 901 claims across 27 drugs.

Dr. Zhao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zhao as offering telehealth.

Dmand AI links 52 papers to Dr. Zhao, published from 2007 to 2020. 2015 was the busiest year, with 5. The most frequent topics are Breast Neoplasms, Cell Line, Tumor and Antineoplastic Agents. Dr. Zhao has published most often in Cancer Res. Dr. Zhao's most frequent co-authors are Jenny C. Chang, MD, Angel A. Rodriguez, MD and Banu K. Arun, MD.

Dmand AI links Dr. Zhao to 7 clinical trials, 6 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Neoplasms, Male and Carcinoma, Intraductal, Noninfiltrating. National Cancer Institute (NCI) sponsors the most, 3.

CMS Open Payments shows 286 general payments to Dr. Zhao from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $651.

Dr. Zhao graduated from Southeast University Medical College in 1997.

Dr. Zhao is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.